Physician profile
Sandford Schocket
NPI 1851381818
$21,742.34
in general payments reported to CMS, 2019-2025
37 companies · $1,621 in 2025
The $1,621 reported for 2025 was more than what 78% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,919 · 2020: $3,739 · 2021: $2,126 · 2022: $2,894 · 2023: $922 · 2024: $1,522 · 2025: $1,621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,064.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,171.62 | 2019-2025 | Proclaim |
| Stimwave Technologies Incorporated | $7,028.88 | 2019-2022 | |
| Medtronic, INC. | $1,283.66 | 2021-2025 | Vanta Adaptivestim, Intellis Adaptivestim, Synchromedii |
| Spr Therapeutics, INC | $1,074.23 | 2019-2020 | |
| Boston Scientific Corporation | $961.55 | 2019-2025 | Intracept |
| Spinal Simplicity, LLC | $653.23 | 2021-2025 | Ha Minuteman G3-R |
| Relievant Medsystems, INC. | $364.22 | 2022-2023 | Intracept |
| Nevro Corp. | $292.01 | 2019-2024 | Senza |
| Foundation Fusion Solutions, LLC | $238.45 | 2021 | |
| Abbvie INC. | $221.21 | 2021-2022 | |
| Globus Medical, INC. | $215.46 | 2025 | Senza |
| Curonix LLC | $165.23 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertiflex, INC. | $130.23 | 2019 | |
| Pfizer INC. | $126.47 | 2019-2025 | |
| Medtronic USA, INC. | $93.73 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $84.36 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $81.43 | 2019-2022 | |
| Allergan, INC. | $68.25 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $45.85 | 2021 | |
| Novartis Pharmaceuticals Corporation | $45.16 | 2020-2021 | |
| Amgen INC. | $41.13 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $40.77 | 2019-2020 | |
| Nalu Medical, INC. | $40.22 | 2021 | |
| Scilex Pharmaceuticals INC. | $32.48 | 2020-2021 | |
| Convatec INC. | $32.37 | 2024-2025 | |
| Tersera Therapeutics LLC | $30.36 | 2025 | Prialt |
| Pacira Pharmaceuticals Incorporated | $24.25 | 2025 | Exparel, Iovera |
| Depuy Synthes Sales INC. | $19.90 | 2020 | |
| Grt US Holding, INC. | $19.81 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.70 | 2023 | Relistor |
| Horizon Therapeutics Plc | $16.94 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $16.39 | 2019 | |
| Daiichi Sankyo INC. | $14.87 | 2019 | |
| Shionogi INC | $14.43 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.30 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.53 | 2019 | |
| Forte Bio-Pharma LLC | $9.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandford Schocket listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.